U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea
· Delayed Price · Currency is KRW 19,490
-910 (-4.46%)
At close: Apr 28, 2026
U2Bio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2014 | 2013 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '14 Dec 31, 2014 | 2013 |
| Net Income | -1,642 | -2,840 | 645.9 | 13,160 | 271.68 | Upgrade
|
| Depreciation & Amortization | 834.91 | 877.21 | 918.87 | 887.97 | 231.75 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -6.21 | 71.54 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 36.91 | -13.64 | 51.69 | 22.7 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 113.4 | 14.99 | 242.13 | 64.81 | - | Upgrade
|
| Other Operating Activities | 811.63 | 1,466 | -2,765 | 2,961 | 578.39 | Upgrade
|
| Change in Accounts Receivable | -1,167 | 401.31 | 2,393 | 11,746 | -2,019 | Upgrade
|
| Change in Inventory | -10.41 | 55.22 | -87.22 | -74.1 | 104.44 | Upgrade
|
| Change in Accounts Payable | -49.61 | -980.22 | -945.32 | -3,934 | 55.57 | Upgrade
|
| Change in Other Net Operating Assets | -489.75 | -712.05 | -3,002 | -499.46 | -209.08 | Upgrade
|
| Operating Cash Flow | -1,562 | -1,731 | -2,555 | 24,406 | -986.6 | Upgrade
|
| Capital Expenditures | -91.62 | -43.39 | -214.43 | -967.1 | -495.43 | Upgrade
|
| Sale (Purchase) of Intangibles | -109.8 | -310.08 | -618 | -175 | -213.93 | Upgrade
|
| Investment in Securities | -12,923 | -16,000 | 33,987 | -35,478 | -75 | Upgrade
|
| Other Investing Activities | -61.5 | 20.72 | 50 | -66.72 | -34.26 | Upgrade
|
| Investing Cash Flow | -13,148 | -16,333 | 33,205 | -36,686 | -840.28 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 1,650 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 600 | Upgrade
|
| Total Debt Issued | - | - | - | - | 2,250 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -700 | -1,715 | Upgrade
|
| Long-Term Debt Repaid | -415.9 | -398.64 | -418.8 | -1,314 | - | Upgrade
|
| Total Debt Repaid | -415.9 | -398.64 | -418.8 | -2,014 | -1,715 | Upgrade
|
| Net Debt Issued (Repaid) | -415.9 | -398.64 | -418.8 | -2,014 | 535 | Upgrade
|
| Issuance of Common Stock | - | - | 5,215 | - | 2,000 | Upgrade
|
| Dividends Paid | - | -338.62 | -1,263 | -757.65 | - | Upgrade
|
| Other Financing Activities | -20.33 | - | -325.66 | - | - | Upgrade
|
| Financing Cash Flow | -436.23 | -737.26 | 3,207 | -2,771 | 2,535 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | - | Upgrade
|
| Net Cash Flow | -15,147 | -18,801 | 33,858 | -15,052 | 708.12 | Upgrade
|
| Free Cash Flow | -1,654 | -1,775 | -2,769 | 23,439 | -1,482 | Upgrade
|
| Free Cash Flow Margin | -6.46% | -7.09% | -8.99% | 33.96% | -13.47% | Upgrade
|
| Free Cash Flow Per Share | -142.02 | -157.44 | -268.41 | 2320.73 | -1025.56 | Upgrade
|
| Cash Interest Paid | 37.23 | 42.62 | 36.32 | 38.44 | - | Upgrade
|
| Cash Income Tax Paid | 37.01 | -75.08 | 2,890 | 190.19 | - | Upgrade
|
| Levered Free Cash Flow | -1,883 | -2,709 | -4,676 | - | -1,962 | Upgrade
|
| Unlevered Free Cash Flow | -1,860 | -2,682 | -4,653 | - | -1,728 | Upgrade
|
| Change in Working Capital | -1,717 | -1,236 | -1,641 | 7,238 | -2,068 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.